General discussion, page-126

It is one of the very few companies to use whole of plant for their drugs. Most just use CBD. The benefits of whole of plant are huge, And it has only been the legal status of THC that has prevented more research into it.
Check out their drug being trialed to reduce opioid addiction.
Management move to the US has not provided much love. But the recent consolidation has removed a lot of performance shares This is very positive, as there were so many before share price vs market cap was questionable.

I hold for a couple of reasons. The main being the whole of plant approach to cannabis medicine. The benefits of this are well documented. There pain drug and hope 1 and 2 show promise.
A friend has a child who has a very hard time with autism. Hope 2 has been life changing for that family.

Recent changes have removed some risk. Consolidation being part of that. But we still need to see management get drugs to market and increase sales and gain some market following.

Lets see